share_log

6-K: Fasenra Recommended for Approval in the EU by CHMP for the Treatment of Eosinophilic Granulomatosis with Polyangiitis

6-K: Fasenra Recommended for Approval in the EU by CHMP for the Treatment of Eosinophilic Granulomatosis with Polyangiitis

6-K:CHMP推薦Fasenra在歐盟批准用於治療伴有多血管炎的嗜酸性肉芽腫病
美股SEC公告 ·  09/23 06:48
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息